About Allecra
Allecra is a company based in Weil Am Rhein (Germany) founded in 2013. Allecra has raised $44.44 million across 2 funding rounds from investors including Edmond de Rothschild, Forbion and EMBL Ventures. Allecra operates in a competitive market with competitors including Paratek Pharma, Spero Therapeutics, Cempra, Bugworks Research and Locus Biosciences, among others.
- Headquarter Weil Am Rhein, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Allecra Therapeutics Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$44.44 M (USD)
in 2 rounds
-
Latest Funding Round
$24.75 M (USD), Series B
Jun 15, 2016
-
Investors
Edmond de Rothschild
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Allecra
Unlock access to complete
Unlock access to complete
Funding Insights of Allecra
Allecra has successfully raised a total of $44.44M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $24.75 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Allecra
Allecra has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Edmond de Rothschild, Forbion and EMBL Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on lifescience and healthcare sectors
|
Locked | Locked | Locked | |
|
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Life science companies are supported through strategic investments.
|
Locked | Locked | Locked |
Investor details for Allecra
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allecra
Investment portfolio details for Allecra
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allecra
Detailed financials for Allecra
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allecra Comparisons
Peer comparison for Allecra
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allecra
Allecra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Paratek Pharma, Spero Therapeutics, Cempra, Bugworks Research and Locus Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for antimicrobial resistant infections are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| Locked | Locked | Locked |
Clinical-stage pharmaceutical company focused on developing antibacterials
|
|
| Locked | Locked | Locked |
Drugs for antibiotic-resistant infections and cancer are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for infectious disease and inflammatory indications
|
|
| Locked | Locked | Locked |
Therapies for multi-drug resistant infections are developed using bacteriophages.
|
Detailed competitors of Allecra
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allecra
Complete news archive for Allecra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allecra
Allecra was founded in 2013.
Allecra is headquartered in Weil Am Rhein, Germany. It is registered at Weil Am Rhein, Baden-wurttemberg, Germany.
Allecra is a funded company, having raised a total of $44.44M across 2 funding rounds to date.
Allecra was founded in 2013 and operates in the biotechnology sector, where antibiotics are developed to address multi-drug-resistant bacterial infections. Two product candidates, cefepime and enmetazobactam, have been created specifically for Gram-negative infections, such as complicated urinary tract infections. Focus is placed on combating antibiotic resistance through targeted therapeutic advancements.
Allecra's top competitors include Spero Therapeutics, Melinta Therapeutics and Vedanta Biosciences.
Allecra has 4 investors. Key investors include Edmond de Rothschild, Forbion, EMBL Ventures, and Delos Capital Partners.